Skip to main content
Log in

Bismuth adjuvant and adverse effects of chemotherapy: issues with statistical analyses

  • Letter to the editor
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

The Original Article was published on 13 December 2016

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Hansen PB, Penkowa M (2017) Bismuth adjuvant ameliorates adverse effects of high-dose chemotherapy in patients with multiple myeloma and malignant lymphoma undergoing autologous stem cell transplantation: a randomised, double-blind, prospective pilot study. Support Care Cancer 25:1279. https://doi.org/10.1007/s00520-016-3522-6

    Article  PubMed  Google Scholar 

  2. R Core Team (2016). R: a language and environment for statistical computing. Vienna, Austria

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Claus Thorn Ekstrøm.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dalgaard, P., Ekstrøm, C.T. & Kronborg, D. Bismuth adjuvant and adverse effects of chemotherapy: issues with statistical analyses. Support Care Cancer 26, 1685–1686 (2018). https://doi.org/10.1007/s00520-017-3859-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-017-3859-5

Navigation